楤木皂苷A在大鼠体内的组织分布研究

2017-11-11 07:26:58郭东艳翟秉涛吕杨史亚军范妤王露王媚
中国中药杂志 2017年20期

郭东艳 翟秉涛 吕杨 史亚军 范妤 王露 王媚

[摘要]楤木皂苷A为太白楤木中的主要活性成分之一。该文通过建立SD大鼠主要脏器中楤木皂苷A的LCMS/MS分析方法,同时口服灌胃楤木皂苷A 50 mg·kg-1,测定大鼠主要脏器(心、肝、脾、肺、肾、脑)中的楤木皂苷A含量,探讨体内的组织分布特征。结果显示楤木皂苷A在SD大鼠主要脏器中的方法学考察符合要求,口服灌胃楤木皂苷A 50 mg·kg-1,在心、肝、脾、肺、肾、脑组织均有分布且在1 h或2 h 时达到最大值。在给药后不同时间点楤木皂苷A的组织分布情况不同:给药20 min各组织含量:肝>心>脾>肺>肾>脑;给药1 h各组织含量:肝>脾>肾>肺>心>脑;给药2 h各组织含量:肝>肾>心>脾>肺>脑;给药4 h各组织含量:肾>肝>脾>心>肺>脑;给药8 h各组织含量:脾>心>肝>肾>肺>脑。提示楤木皂苷A主要分布于肝组织,这也与太白楤木常用于治疗肝脏疾病具有一定的相关性。另外,楤木皂苷A在脑组织中虽含量低但有明显分布,提示药物可能会透过血脑屏障,也为楤木皂苷A在脑组织的研究提供了依据。

[关键词]楤木皂苷A; 组织分布; HPLCMS/MS

[Abstract]Araloside A is one of the main active ingredients of Aralia taibaiensis In this study, HPLCMS/MS analysis method of araloside A in the main organs of SD rats was established At the same time, the content of araloside A in the main organs (heart, liver, spleen, lung, kidney, brain) after oral administration with araloside A (50 mg·kg-1) were determined to explore the tissue distribution characteristics of araloside A in vivo The results showed that the methodological study of araloside A in the main organs of SD rats met the requirements, araloside A distributed in heart, liver, spleen, lung, kidney and brain tissues reached peak at 1 h or 2 h after oral administration with 50 mg·kg-1The distributions of araloside A at different time points after administration were distinct as follows: the content of araloside A at 20 min:liver>heart>spleen>lung>kidney>brain; the content of araloside A at 1 h: liver>spleen>kidney>lung>heart>brain; the content of araloside A at 2 h: liver>kidney>heart>spleen>lung>brain; the content of araloside A at 4 h: kidney>liver>spleen>heart>lung>brain; the content of araloside A at 8 h: spleen>heart>liver>kidney>lung>brain Therefore, araloside A was mainly distributed in liver tissue, which had a certain correlation with the common use of Aralia taibaiensis in the treatment of hepatic disease In addition, araloside A shows a low content but an obvious distribution in brain tissues, which indicates that the drug can pass through bloodbrain barrier, and provides the basis for the study of araloside A in brain tissue

[Key words]araloside A; tissue distribution; HPLCMS/MS

楤木皂苷A(araloside A)為楤木属植物太白楤木Aralia taibaiensis的主要活性成分之一,含量约占太白楤木药材质量的12%,其化学结构见图1。具有抗溃疡、抗肿瘤、促纤溶、降血糖、抑制肾素活性等药理作用[15]。1961年,楤木皂苷A首次被前苏联学者Kochetkov N K等[6]从辽东楤木中分离得到,并运用化学法初步确定其结构。随后的几十年,有关楤木皂苷A的研究报道主要集中在药效方面,而相关的药代动力学研究仅有2篇报道,1篇是Iskenderov G B等[7]1991年发表,而另1篇Qi D等[8]以楤木皂苷A作为指标成分之一,对竹节参提取物进行药动学研究。众所周知,1个药物能否发挥药效,在一定程度上是由胃肠道的吸收和靶器官的浓度决定。药物口服吸收进入机体……

登录APP查看全文